Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
J Thromb Haemost ; 3(12): 2730-7, 2005 Dec.
Article in English | MEDLINE | ID: mdl-16359510

ABSTRACT

The role of factor V Leiden (FVL) as a modifier of the severe hemophilia phenotype is still unclear. We used mice with hemophilia A or B crossed with FVL to elucidate in vivo parameters of hemostasis. Real-time thrombus formation in the microcirculation was monitored by deposition of labeled platelets upon laser-induced endothelial injury using widefield microscopy in living animals. No thrombi formed in hemophilic A or B mice following vascular injuries. However, hemophilic mice, either heterozygous or homozygous for FVL, formed clots at all injured sites. Injection of purified activated FV into hemophilic A or B mice could mimic the in vivo effect of FVL. In contrast to these responses to a laser injury in a microvascular bed, FVL did not provide sustained hemostasis following damage of large vessels in a ferric chloride carotid artery injury model, despite of the improvement of clotting times and high circulating thrombin levels. Together these data provide evidence that FVL has the ability to improve the hemophilia A or B phenotype, but this effect is principally evident at the microcirculation level following a particular vascular injury. Our observations may partly explain the heterogeneous clinical evidence of the beneficial role of FVL in hemophilia.


Subject(s)
Factor V/physiology , Hemophilia A/blood , Hemostasis , Animals , Blood Coagulation/genetics , Carotid Artery Injuries/blood , Disease Models, Animal , Hemophilia A/genetics , Hemophilia B , Hemostasis/genetics , Mice , Mice, Inbred Strains , Microcirculation , Microscopy, Video , Muscle, Skeletal/blood supply
2.
J Immunol ; 167(8): 4351-7, 2001 Oct 15.
Article in English | MEDLINE | ID: mdl-11591759

ABSTRACT

Despite the impressive protection of B cell-deficient (muMT(-/-)) nonobese diabetic (NOD) mice from spontaneous diabetes, existence of mild pancreatic islet inflammation in these mice indicates that initial autoimmune targeting of beta cells has occurred. Furthermore, muMT(-/-) NOD mice are shown to harbor a latent repertoire of diabetogenic T cells, as evidenced by their susceptibility to cyclophosphamide-induced diabetes. The quiescence of this pool of islet-reactive T cells may be a consequence of impaired activation of T lymphocytes in B cell-deficient NOD mice. In this regard, in vitro anti-CD3-mediated stimulation demonstrates impaired activation of lymph node CD4 T cells in muMT(-/-) NOD mice as compared with that of wild-type counterparts, a deficiency that is correlated with an exaggerated CD4 T cell:APC ratio in lymph nodes of muMT(-/-) NOD mice. This feature points to an insufficient availability of APC costimulation on a per T cell basis, resulting in impaired CD4 T cell activation in lymph nodes of muMT(-/-) NOD mice. In accordance with these findings, an islet-reactive CD4 T cell clonotype undergoes suboptimal activation in pancreatic lymph nodes of muMT(-/-) NOD recipients. Overall, the present study indicates that B cells in the pancreatic lymph node microenvironment are critical in overcoming a checkpoint involving the provision of optimal costimulation to islet-reactive NOD CD4 T cells.


Subject(s)
B-Lymphocytes/immunology , CD4-Positive T-Lymphocytes/immunology , Diabetes Mellitus, Type 1/immunology , Islets of Langerhans/immunology , Lymph Nodes/immunology , Animals , B-Lymphocytes/cytology , Cyclophosphamide/adverse effects , Diabetes Mellitus, Type 1/chemically induced , Diabetes Mellitus, Type 1/etiology , Lymph Nodes/cytology , Lymphocyte Activation , Mice , Mice, Inbred NOD , Mice, Mutant Strains , Spleen/cytology , Spleen/immunology
3.
Cell Immunol ; 195(1): 75-9, 1999 Jul 10.
Article in English | MEDLINE | ID: mdl-10433799

ABSTRACT

B lymphocytes are required for diabetogenesis in nonobese diabetic (NOD) mice. The complement component of the innate immune system regulates B cell activation and tolerance through complement receptors CR1/CR2. Thus, it is important to assess the contribution of complement receptors to autoimmune diabetes in NOD mice. Examination of the lymphoid compartments of NOD mice revealed striking expansion of a splenic B cell subset with high cell surface expression of CR1/CR2. This subset of B cells exhibited an enhanced C3 binding ability. Importantly, long-term in vivo blockade of C3 binding to CR1/CR2 prevented the emergence of the CR1/CR2(hi) B cells and afforded resistance to autoimmune diabetes in NOD mice. These findings implicate complement as an important regulatory element in controlling the T cell-mediated attack on islet beta cells of NOD mice.


Subject(s)
Diabetes Mellitus, Type 1/immunology , Receptors, Complement 3b/immunology , Receptors, Complement 3d/immunology , Animals , B-Lymphocytes/immunology , Complement C3/immunology , Immunity, Innate/immunology , Immunophenotyping , Mice , Mice, Inbred BALB C , Mice, Inbred C57BL , Mice, Inbred NOD , Spleen/cytology , Spleen/immunology
4.
J Immunol ; 163(2): 743-50, 1999 Jul 15.
Article in English | MEDLINE | ID: mdl-10395666

ABSTRACT

B cell-deficient nonobese diabetic (NOD) mice are protected from the development of spontaneous autoimmune diabetes, suggesting a requisite role for Ag presentation by B lymphocytes for the activation of a diabetogenic T cell repertoire. This study specifically examines the importance of B cell-mediated MHC class II Ag presentation as a regulator of peripheral T cell tolerance to islet beta cells. We describe the construction of NOD mice with an I-Ag7 deficiency confined to the B cell compartment. Analysis of these mice, termed NOD BCIID, revealed the presence of functionally competent non-B cell APCs (macrophages/dendritic cells) with normal I-Ag7 expression and capable of activating Ag-reactive T cells. In addition, the secondary lymphoid organs of these mice harbored phenotypically normal CD4+ and CD8+ T cell compartments. Interestingly, whereas control NOD mice harboring I-Ag7-sufficient B cells developed diabetes spontaneously, NOD BCIID mice were resistant to the development of autoimmune diabetes. Despite their diabetes resistance, histologic examination of pancreata from NOD BCIID mice revealed foci of noninvasive peri-insulitis that could be intentionally converted into a destructive process upon treatment with cyclophosphamide. We conclude that I-Ag7-mediated Ag presentation by B cells serves to overcome a checkpoint in T cell tolerance to islet beta cells after their initial targeting has occurred. Overall, this work indicates that the full expression of the autoimmune potential of anti-islet T cells in NOD mice is intimately regulated by B cell-mediated MHC class II Ag presentation.


Subject(s)
Antigen Presentation , B-Lymphocytes/immunology , Diabetes Mellitus, Type 1/immunology , Histocompatibility Antigens Class II/physiology , Immune Tolerance , Islets of Langerhans/immunology , T-Lymphocytes/immunology , Animals , Antigen Presentation/genetics , Antigen-Presenting Cells/immunology , Antigen-Presenting Cells/metabolism , B-Lymphocytes/metabolism , B-Lymphocytes/pathology , Bone Marrow Transplantation , Crosses, Genetic , Diabetes Mellitus, Type 1/genetics , Diabetes Mellitus, Type 1/pathology , Female , Genetic Predisposition to Disease/immunology , Histocompatibility Antigens Class II/genetics , Immune Tolerance/genetics , Immunity, Innate/genetics , Immunophenotyping , Islets of Langerhans/pathology , Lymphopenia/genetics , Lymphopenia/immunology , Mice , Mice, Inbred BALB C , Mice, Inbred C57BL , Mice, Inbred NOD , Mice, SCID , Mice, Transgenic , Radiation Chimera/genetics , Radiation Chimera/immunology
SELECTION OF CITATIONS
SEARCH DETAIL
...